About
Adirna Therapeutics develops RNA-based precision medicines by leveraging AI and big data to identify and target non-coding regions of the genome for novel therapeutic discovery.
Explore Adirna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.